Literature DB >> 4903318

Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.

T M Chalmers, J E Pohl, D S Platt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4903318      PMCID： PMC1031292          DOI： 10.1136/ard.28.6.590

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  ABNORMALITIES OF SERUM PROTEINS AS CRITERIA FOR THE DIAGNOSIS OF ACUTE RHEUMATIC FEVER.

Authors:  S H BERNSTEIN; J ALLERHAND
Journal:  Am J Med Sci       Date:  1964-04       Impact factor: 2.378

2.  Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity.

Authors:  R C REYNOLDS; L E CLUFF
Journal:  Bull Johns Hopkins Hosp       Date:  1960-11

3.  Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.

Authors:  W M Hammer; B B Brodiet
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

4.  Rate of accumulation and plateau plasma concentration of drugs after chronic medication.

Authors:  J M van Rossum; A H Tomey
Journal:  J Pharm Pharmacol       Date:  1968-05       Impact factor: 3.765

5.  CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT.

Authors:  B B NEWBOULD
Journal:  Br J Pharmacol Chemother       Date:  1963-08
  5 in total
  5 in total

1.  Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.

Authors:  L O Erikson; E Wåhlin-Boll; I Odar-Cederlöf; L Lindholm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease.

Authors:  P R Crook; J V Willis; M J Kendall; D B Jack; P D Fowler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.

Authors:  T M Chalmers; J H Kellgren; D S Platt
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

4.  Acute liver effects, disposition and metabolic fate of [14C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.

Authors:  Kathryn Pickup; Scott Martin; Elizabeth A Partridge; Huw B Jones; Jonathan Wills; Tim Schulz-Utermoehl; Alan McCarthy; Alison Rodrigues; Chris Page; Kerry Ratcliffe; Sunil Sarda; Ian D Wilson
Journal:  Arch Toxicol       Date:  2016-11-28       Impact factor: 5.153

5.  The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.

Authors:  Anja Ekdahl; Lars Weidolf; Matthew Baginski; Yoshio Morikawa; Richard A Thompson; Ian D Wilson
Journal:  Arch Toxicol       Date:  2018-08-09       Impact factor: 5.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.